You are now leaving Lundbeck UK's website (www.lundbeck.com/uk) for an external website. External links are provided as a resource to the viewer. Lundbeck UK are not responsible for the external website and its content.
UK-NOTPR-1010 | April 2022
Lundbeck’s compliance hotline
Lundbeck's Compliance Hotline
The Compliance Hotline is a secure and confidential reporting channel managed by an independent provider. When reporting a concern in good faith you will be protected by Lundbeck's Non-Retaliation policy, as referred to below.
What can be reported?
Due to legal restrictions, only concerns that involve legal, serious financial or reputational risks may be reported via the Compliance Hotline. You can find examples of specific allegations that may and may not be reported on the "What May Be Reported (List of Allegations) " link below.
How to report?
You can report your concern online using the Compliance Hotline Link, which supports multiple languages and is always reachable. You can also use the Lundbeck Compliance Hotline App available on Apple Store and Google Play.
After reporting
All reported concerns will be investigated by Lundbeck experts. After submitting the report, you can anonymously communicate with the investigator using your case reference number through the Compliance Hotline. Concerns that are substantiated will be followed by corrective and preventive actions.
Lundbeck's non-retaliation policy
Lundbeck will not accept any retaliation or discrimination against any employee or external stakeholder who uses our Compliance Hotline in good faith or participates in an investigation. Any employee who breaches this policy will be subject to disciplinary actions.
Data Privacy
All personal data collected through the Compliance Hotline will be processed in accordance with the applicable regulations.
Please see our Data Privacy Notification here for further information.
More from Lundbeck
Scientific partnerships
Our heritage and success have provided us with a strong global network.
About us
A global pharmaceutical company specialising in brain diseases.
Press
For general press enquiries, please call + 45 3643 4000.
UK-NOTPR-2211 | October 2024